Standing out from the crowd

We’ve all been there. Someone sent you something but you missed it. It wasn’t sent via your preferred channel. You have been inundated with emails, messages on Teams, WhatsApp, iMessage, etc… the list goes on. And you simply didn’t see it through the mass of communication we receive daily. It’s a common challenge that marketers face – how do you get your message in front of the right people at the right time, and most importantly, make sure they read it?

Relevance. If your message is not relevant to the recipient, why would it stand out? A recent article in Pharmaphorum talks about the digital deluge of content HCPs receive. The shift change to digital engagement has been swift but with it, a tendency to just push content out without considering its relevance to the recipient.

Effective HCP engagement is essential for pharma. Communicating digital peer-reviewed scientific articles (ePrints) from leading medical publishers – in line with HCP needs and interests ensures relevance and drives communication effectiveness as demonstrated by research by Across Health, CMI Media Group, Clarivate and many others.

Tangent90 develop solutions that address the challenges in distributing ePrints such as copyright protection, adherence to terms and conditions and tracking, enabling pharma to share digital copyright content directly with HCPs, through their existing channels as well as third-party channels. We have built up our experience with pharma over many years. As a leading SaaS company, we work with 15 out of the top 25 global pharma companies. Our credentials are further evidenced by our Veeva Silver Certified Technology Partners status – one of the first-ever partners to achieve Silver status and of course the publishing industry partnerships.

To find out more about how Tangent90 can support you in managing your scientific content distribution, please contact us at

Related news

HCP access

Taking advantage of the HCP access rebound

The latest Veeva Pulse Field Trends Report is out and it discusses the change in access to HCPs. Even pre-pandemic, face-to-face meetings were in decline but the report highlights that this has bounced back, and some. The figure now sits at 60% across all specialities but what is clear is that how interaction takes place has changed.

Marketing insight

Harnessing data-driven HCP engagement

Whether it’s via email, from a congress booth, or a website, we share content with our target audience constantly. For pharma, this content can be the difference between an HCP prescribing their drug or not. It is, therefore, important to understand what happens to that content after the initial interaction with the HCP.


Next-level engagement at congress

Around 40% of congresses are now operating a hybrid format therefore optimising the whole experience has become a priority, from the initial transaction to providing measurable outcomes – it requires a complete organisational approach.

Scroll to Top

Book A Demo

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.